Prevalence, Incidence, and Clinical Relevance of the Reverse Transcriptase V207I Mutation Outside the YMDD Motif of the Hepatitis B Virus Polymerase during Lamivudine Therapy

The reverse transcriptase V207I mutation within the hepatitis B virus (HBV) polymerase is associated with resistance to lamivudine in vitro. The prevalence of this mutation in treatment-naïve patients was 1% (1/96). A follow-up of the patient carrying this mutation prior to treatment revealed no los...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zöllner, B., Sterneck, M., Wursthorn, K., Petersen, J., Schröter, M., Laufs, R., Feucht, H.-H.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2005
Materias:
Virology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1153772/
https://ncbi.nlm.nih.gov/pubmed/15872296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.43.5.2503-2505.2005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares